IL136551A0 - Preparation of peg-grf conjugates - Google Patents
Preparation of peg-grf conjugatesInfo
- Publication number
- IL136551A0 IL136551A0 IL13655198A IL13655198A IL136551A0 IL 136551 A0 IL136551 A0 IL 136551A0 IL 13655198 A IL13655198 A IL 13655198A IL 13655198 A IL13655198 A IL 13655198A IL 136551 A0 IL136551 A0 IL 136551A0
- Authority
- IL
- Israel
- Prior art keywords
- grf
- conjugates
- peg
- preparation
- grf conjugates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97121264A EP0922446A1 (en) | 1997-12-03 | 1997-12-03 | Solution-phase site-specific preparation of GRF-PEG conjugates |
| PCT/EP1998/007748 WO1999027897A1 (en) | 1997-12-03 | 1998-12-01 | Site-specific preparation of polyethylene glycol-grf conjugates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL136551A0 true IL136551A0 (en) | 2001-06-14 |
Family
ID=8227732
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13655198A IL136551A0 (en) | 1997-12-03 | 1998-12-01 | Preparation of peg-grf conjugates |
| IL136551A IL136551A (en) | 1997-12-03 | 2000-06-04 | Preparation of peg-grf conjugates |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL136551A IL136551A (en) | 1997-12-03 | 2000-06-04 | Preparation of peg-grf conjugates |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US6528485B1 (pl) |
| EP (2) | EP0922446A1 (pl) |
| JP (2) | JP2001524505A (pl) |
| KR (1) | KR100561768B1 (pl) |
| CN (1) | CN1149967C (pl) |
| AR (1) | AR017780A1 (pl) |
| AT (1) | ATE236607T1 (pl) |
| AU (1) | AU755285B2 (pl) |
| BG (1) | BG64815B1 (pl) |
| BR (1) | BR9815159A (pl) |
| CA (1) | CA2312004C (pl) |
| DE (1) | DE69813291T2 (pl) |
| DK (1) | DK1037587T3 (pl) |
| EA (1) | EA004269B1 (pl) |
| EE (1) | EE200000319A (pl) |
| ES (1) | ES2194376T3 (pl) |
| HU (1) | HUP0100507A3 (pl) |
| IL (2) | IL136551A0 (pl) |
| NO (1) | NO327238B1 (pl) |
| NZ (1) | NZ504570A (pl) |
| PL (1) | PL192082B1 (pl) |
| PT (1) | PT1037587E (pl) |
| SI (1) | SI1037587T1 (pl) |
| SK (1) | SK8242000A3 (pl) |
| TR (1) | TR200001615T2 (pl) |
| TW (1) | TWI254641B (pl) |
| UA (1) | UA73716C2 (pl) |
| WO (1) | WO1999027897A1 (pl) |
| ZA (1) | ZA9811068B (pl) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010055581A1 (en) | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
| US7229841B2 (en) * | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
| US6407218B1 (en) * | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
| CA2422707A1 (en) | 2000-10-05 | 2002-04-11 | Ares Trading S.A. | Regioselective liquid phase pegylation |
| EP1234583A1 (en) * | 2001-02-23 | 2002-08-28 | F. Hoffmann-La Roche Ag | PEG-conjugates of HGF-NK4 |
| US20030171285A1 (en) * | 2001-11-20 | 2003-09-11 | Finn Rory F. | Chemically-modified human growth hormone conjugates |
| ES2291613T3 (es) | 2002-01-16 | 2008-03-01 | Biocompatibles Uk Limited | Conjugados de polimeros. |
| US7998705B2 (en) * | 2002-08-06 | 2011-08-16 | FUJIFILM Diosynth Biotechnologies U.S.A., Inc | Increased dynamic binding capacity in ion exchange chromatography by addition of polyethylene glycol |
| RU2005111253A (ru) * | 2002-09-18 | 2005-11-20 | Сантр Оспиталье Де Л` Юниверсите Де Монреаль (Схюм) (Ca) | Аналоги ghrh |
| GB0301014D0 (en) * | 2003-01-16 | 2003-02-19 | Biocompatibles Ltd | Conjugation reactions |
| EP1585758A4 (en) * | 2003-01-18 | 2006-06-07 | Pegsphere Co Ltd | PEPTIDES WITH PROTECTED AMINES OF UNCENTRICATED PLACES, METHOD OF MANUFACTURING THEREOF AND OF SPECIFICALLY CONJUGATED PEG-PEPTIDES THEREWITH |
| US20050058658A1 (en) * | 2003-07-15 | 2005-03-17 | Barros Research Institute | Compositions and methods for immunotherapy of human immunodeficiency virus (HIV) |
| JP2008500005A (ja) * | 2003-07-15 | 2008-01-10 | バロス リサーチ インスティテュート | 癌及び感染症の免疫療法のための組成物及び方法 |
| CA2548179A1 (en) * | 2003-12-02 | 2005-07-21 | Cytimmune Sciences, Inc. | Methods and compositions for the production of monoclonal antibodies |
| JP4833862B2 (ja) * | 2004-01-28 | 2011-12-07 | サイトイミューン サイエンシズ インコーポレイテッド | 官能化コロイド金属組成物および方法 |
| CN100355784C (zh) * | 2004-02-12 | 2007-12-19 | 江苏恒瑞医药股份有限公司 | 聚乙二醇修饰α－干扰素1b的制备方法 |
| US20050261475A1 (en) * | 2004-02-13 | 2005-11-24 | Harvard Medical School | Solid-phase capture-release-tag methods for phosphoproteomic analyses |
| US6986264B1 (en) * | 2004-07-15 | 2006-01-17 | Carrier Corporation | Economized dehumidification system |
| US7632921B2 (en) | 2004-11-12 | 2009-12-15 | Bayer Healthcare Llc | Site-directed modification of FVIII |
| US20070027301A1 (en) * | 2005-07-26 | 2007-02-01 | Gabriella Cristobal-Lumbroso | Polymers with pendant poly(alkyleneoxy) substituent groups and their use in personal care applications |
| US20070238656A1 (en) * | 2006-04-10 | 2007-10-11 | Eastman Kodak Company | Functionalized poly(ethylene glycol) |
| US20080096819A1 (en) * | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
| US7632492B2 (en) | 2006-05-02 | 2009-12-15 | Allozyne, Inc. | Modified human interferon-β polypeptides |
| CA2659990C (en) * | 2006-08-04 | 2016-03-22 | Prolong Pharmaceuticals, Inc. | Polyethylene glycol erythropoietin conjugates |
| US20080083154A1 (en) * | 2006-10-05 | 2008-04-10 | Timothy M Gregory | Bait retention fish hook |
| RU2345608C2 (ru) * | 2007-01-09 | 2009-02-10 | Государственное образовательное учреждение высшего профессионального образования "Северо-Кавказский государственный технический университет" | Вареная колбаса с использованием pse свинины и способ ее производства |
| CA2707840A1 (en) | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
| US20110014118A1 (en) * | 2007-09-21 | 2011-01-20 | Lawrence Tamarkin | Nanotherapeutic colloidal metal compositions and methods |
| WO2009039502A1 (en) * | 2007-09-21 | 2009-03-26 | Cytimmune Sciences, Inc. | Nanotherapeutic colloidal metal compositions and methods |
| WO2009062151A1 (en) | 2007-11-08 | 2009-05-14 | Cytimmune Sciences, Inc. | Compositions and methods for generating antibodies |
| WO2010053990A2 (en) * | 2008-11-04 | 2010-05-14 | Janssen Pharmaceutica Nv | Crhr2 peptide agonists and uses thereof |
| HRP20161055T1 (hr) * | 2009-03-20 | 2016-11-04 | Hanmi Science Co., Ltd. | Postupak proizvodnje konjugata specifičnog za mjesto od fiziološki djelotvornog polipeptida |
| EP2421548A4 (en) * | 2009-04-20 | 2012-09-26 | Theratechnologies Inc | USE OF (HEXENOYL TRANS-3) HGRF (1-44) NH2 AND SIMVASTATIN IN COMBINED TREATMENT |
| WO2010121351A1 (en) * | 2009-04-20 | 2010-10-28 | Theratechnologies Inc. | Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy |
| JP5906184B2 (ja) | 2009-06-22 | 2016-04-20 | バーナム インスティテュート フォー メディカル リサーチ | Ｃ末端エレメントを有するペプチドおよびタンパク質を使用する方法および組成物 |
| MX2012005262A (es) * | 2009-11-04 | 2012-09-28 | Janssen Pharmaceutica Nv | Metodo para tratar la insuficiencia cardiaca con petidos tipo estrescopina. |
| WO2012118778A1 (en) | 2011-02-28 | 2012-09-07 | Sanford-Burnham Medical Research Institute | Truncated car peptides and methods and compositions using truncated car peptides |
| JP6113144B2 (ja) | 2011-04-21 | 2017-04-12 | セラテクノロジーズ・インコーポレーテッド | 成長ホルモン放出因子（ｇｒｆ）類似体およびその使用 |
| CA2837588A1 (en) | 2011-05-31 | 2012-12-06 | Airware, Inc. | Re-calibration of ab ndir gas sensors |
| US10179801B2 (en) | 2011-08-26 | 2019-01-15 | Sanford-Burnham Medical Research Institute | Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides |
| WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| US10064940B2 (en) | 2013-12-11 | 2018-09-04 | Siva Therapeutics Inc. | Multifunctional radiation delivery apparatus and method |
| EP3303378B1 (en) | 2015-05-28 | 2021-04-21 | Institut National de la Recherche Scientifique | Inhibitors of prototypic galectin dimerization and uses thereof |
| JP7134093B2 (ja) * | 2016-04-19 | 2022-09-09 | グリフォン・ファーマシューティカルズ・アンテルナシオナル・エスアー | ペグ化バイオアクティブペプチド及びその使用 |
| CN110317826B (zh) * | 2019-05-22 | 2020-11-10 | 中国农业大学 | 调控PvGRF9含量或活性的物质在调控植物茎生长发育中的应用 |
| JP7665215B2 (ja) | 2019-12-19 | 2025-04-21 | トランスフェルト・プラス・ソシエテ・アン・コマンディテ | 腸のニューロパチーを治療するためのグリア細胞株由来神経栄養因子（ｇｄｎｆ）の使用 |
| WO2021133407A1 (en) | 2019-12-27 | 2021-07-01 | Compagnie Generale Des Etablissements Michelin | Rubber mix with high specific surface area and high structure acetylene carbon black |
| CA3206260A1 (en) | 2021-01-28 | 2022-08-04 | Ilse Roodink | Anti-sars-cov-2 spike glycoprotein antibodies and the therapeutic use thereof |
| WO2024081918A1 (en) | 2022-10-14 | 2024-04-18 | Talem Therapeutics Llc | Anti-trkb/cd3 antibodies and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4563352A (en) * | 1982-10-04 | 1986-01-07 | The Salk Institute For Biological Studies | Human pancreatic GRF |
| ES2085297T3 (es) * | 1989-05-27 | 1996-06-01 | Sumitomo Pharma | Procedimiento para preparar derivados de poli(etilenglicol) y proteina modificada. |
| EP0544706A4 (en) * | 1990-06-29 | 1993-10-13 | Hoffmann-La Roche Inc. | Histidine substituted growth hormone releasing factor analogs |
| JP3051145B2 (ja) * | 1990-08-28 | 2000-06-12 | 住友製薬株式会社 | 新規なポリエチレングリコール誘導体修飾ペプチド |
| WO1992018531A1 (en) * | 1991-04-09 | 1992-10-29 | F. Hoffmann-La Roche Ag | Growth hormone releasing factor analogs |
| EP0518295A3 (en) * | 1991-06-14 | 1993-09-01 | Millipore Corporation | Allyl side chain protection in peptide synthesis |
| FR2687681B1 (fr) * | 1992-02-20 | 1995-10-13 | Transgene Sa | Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses. |
| US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| AU7273196A (en) * | 1995-11-03 | 1997-05-29 | Theratechnologies Inc. | Method of grf peptides synthesis |
-
1997
- 1997-12-03 EP EP97121264A patent/EP0922446A1/en not_active Withdrawn
-
1998
- 1998-01-12 UA UA2000063885A patent/UA73716C2/uk unknown
- 1998-12-01 EE EEP200000319A patent/EE200000319A/xx unknown
- 1998-12-01 SI SI9830400T patent/SI1037587T1/xx unknown
- 1998-12-01 BR BR9815159-2A patent/BR9815159A/pt not_active Application Discontinuation
- 1998-12-01 WO PCT/EP1998/007748 patent/WO1999027897A1/en not_active Ceased
- 1998-12-01 EA EA200000601A patent/EA004269B1/ru not_active IP Right Cessation
- 1998-12-01 ES ES98959898T patent/ES2194376T3/es not_active Expired - Lifetime
- 1998-12-01 PL PL341139A patent/PL192082B1/pl not_active IP Right Cessation
- 1998-12-01 AU AU15633/99A patent/AU755285B2/en not_active Expired
- 1998-12-01 CN CNB988117592A patent/CN1149967C/zh not_active Expired - Fee Related
- 1998-12-01 JP JP2000522885A patent/JP2001524505A/ja active Pending
- 1998-12-01 EP EP98959898A patent/EP1037587B1/en not_active Expired - Lifetime
- 1998-12-01 TR TR2000/01615T patent/TR200001615T2/xx unknown
- 1998-12-01 PT PT98959898T patent/PT1037587E/pt unknown
- 1998-12-01 DE DE69813291T patent/DE69813291T2/de not_active Expired - Lifetime
- 1998-12-01 CA CA002312004A patent/CA2312004C/en not_active Expired - Lifetime
- 1998-12-01 DK DK98959898T patent/DK1037587T3/da active
- 1998-12-01 HU HU0100507A patent/HUP0100507A3/hu unknown
- 1998-12-01 NZ NZ504570A patent/NZ504570A/en unknown
- 1998-12-01 SK SK824-2000A patent/SK8242000A3/sk unknown
- 1998-12-01 IL IL13655198A patent/IL136551A0/xx unknown
- 1998-12-01 KR KR1020007005736A patent/KR100561768B1/ko not_active Expired - Fee Related
- 1998-12-01 AT AT98959898T patent/ATE236607T1/de active
- 1998-12-02 AR ARP980106098A patent/AR017780A1/es active IP Right Grant
- 1998-12-03 ZA ZA9811068A patent/ZA9811068B/xx unknown
-
1999
- 1999-01-26 TW TW088101139A patent/TWI254641B/zh not_active IP Right Cessation
-
2000
- 2000-05-24 NO NO20002664A patent/NO327238B1/no not_active IP Right Cessation
- 2000-05-29 BG BG10448A patent/BG64815B1/bg unknown
- 2000-06-04 IL IL136551A patent/IL136551A/en not_active IP Right Cessation
- 2000-06-05 US US09/587,460 patent/US6528485B1/en not_active Expired - Lifetime
-
2002
- 2002-11-20 US US10/299,790 patent/US6869932B2/en not_active Expired - Lifetime
-
2004
- 2004-12-15 US US11/011,617 patent/US7317002B2/en not_active Expired - Fee Related
-
2009
- 2009-10-30 JP JP2009251100A patent/JP5431874B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL136551A0 (en) | Preparation of peg-grf conjugates | |
| GB9713980D0 (en) | New conjugates | |
| EP1020193A4 (en) | ORAL PREPARATION | |
| GB9713703D0 (en) | Preparation of opiates | |
| PL339551A1 (en) | Derivatives of rezorcin | |
| GB9715751D0 (en) | Formulations | |
| EP1017379A4 (en) | THERAPEUTIC COMPOSITIONS | |
| EP1033994A4 (en) | METHOD FOR PRODUCING BIOGINKGO | |
| PL335700A1 (en) | Novel preparation | |
| PL337970A1 (en) | Novel preparation | |
| EP0976381A4 (en) | PREPARATION FOR DERMATOLOGICAL USE | |
| ZA982073B (en) | Pharmaceutical preparation | |
| PL334769A1 (en) | Derivatives of 5-aroylnaphtene | |
| CY2590B2 (en) | Preparation of 1-butyl-4-piperidinylmethylamine | |
| HUP9902855A3 (en) | Preparation of sterol- and stanol-esters | |
| AU8102498A (en) | Preparation of diaryl-benzopyrans | |
| PL338777A1 (en) | Derivative of piperidinylmethyloxazolydinone | |
| ZA985064B (en) | Derivatives of pentaerythrits | |
| IL124387A0 (en) | Preparation of 5-Methyleneoxazolines | |
| GB2329384B (en) | Preparation of 1-chloro-1-cyclopropylethene | |
| PL325816A1 (en) | Novel derivatives of naphtylpiperazine | |
| GB2322372B (en) | Preparation of 2-Mercaptothiazole | |
| GB9702652D0 (en) | Conjugates and their preparation | |
| TW319017U (en) | Improved structure of mousetraps | |
| TW312301U (en) | Improved structure of earmask |